Last reviewed · How we verify

thiazide diuretics

Seiji Umemoto, M.D., Ph.D. · FDA-approved active Small molecule

Thiazide diuretics inhibit sodium and chloride reabsorption in the distal convoluted tubule of the nephron, increasing urine output and reducing blood volume and blood pressure.

Thiazide diuretics inhibit sodium and chloride reabsorption in the distal convoluted tubule of the nephron, increasing urine output and reducing blood volume and blood pressure. Used for Hypertension, Edema associated with congestive heart failure, Edema associated with hepatic cirrhosis.

At a glance

Generic namethiazide diuretics
Also known asbenidipie, thiazide diuretics
SponsorSeiji Umemoto, M.D., Ph.D.
Drug classThiazide diuretic
TargetSodium-chloride cotransporter (NCC)
ModalitySmall molecule
Therapeutic areaCardiovascular
PhaseFDA-approved

Mechanism of action

Thiazides block the sodium-chloride cotransporter (NCC) in the distal convoluted tubule, preventing electrolyte reabsorption and promoting osmotic diuresis. This reduces intravascular volume and total body sodium, leading to decreased blood pressure. Over time, they also cause mild vasodilation through unknown mechanisms, contributing to sustained antihypertensive effects.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results